Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Steven Gillis

Affiliations

  • Director at Vbi Vaccines Inc (VBIV), 2019-06-18
  • Director at Homology Medicines Inc. (FIXX), 2019-06-10
  • Director at Pulmatrix Inc. (PULM), 2019-05-20
  • Large Shareholder at Sienna Biopharmaceuticals Inc. (SNNA), 2019-02-27
  • Large Shareholder, Director at Phaserx Inc. (PZRX), 2017-05-30
  • Large Shareholder, Director at Vbi Vaccines Inc. (VBIV), 2015-08-18
  • Director at Bluebird Bio Inc. (BLUE), 2015-07-30
  • Ex. Chair. & President at Trubion Pharmaceuticals Inc (TRBN), 2010-10-28
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PULM $0.00 1,150,000 Director 3,436,456 2018-04-03 Filing
VBIV $3.05 300,000 Director 3,026,057 2017-10-30 Filing
PZRX $5.00 1,000,000 Large Shareholder, Director 2,854,222 2016-05-23 Filing
PULM $6.88 72,750 Director 2,286,456 2015-06-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PZRX $0.01 195,156 Large Shareholder, Director 1,854,222 2016-05-23 Filing
PZRX $0.01 484,903 Large Shareholder, Director 2,049,378 2016-05-23 Filing
BLUE $35.25 115,000 Director 1,041,111 2014-10-09 Filing
BLUE $35.15 6,700 Director 1,156,111 2014-10-07 Filing
BLUE $35.16 24,100 Director 1,162,811 2014-10-06 Filing